John Q Doyle

CEO John Q Doyle sold 16,656 shares of MRSH at $161.71 on 2026-06-02 via pre-arranged 10b5-1 plan; holds 116,811 non-derivative shares post-transaction.

President and CEO John Q Doyle executed a scheduled sale of 16,656 shares at $161.71 under a pre-arranged 10b5-1 trading plan on 2026-06-02, reducing his non-derivative holdings to 116,811 shares from 133,467 shares (-12.5%). The transaction is part of a predetermined plan rather than a discretionary decision, removing timing-based interpretation. The stock has since declined 18.6% from its 52-week high of $193.32 and is currently trading at $157.32, below the transaction price. While this marks a scheduled vest-and-sell action, Doyle retains 33,312 shares through stock options, maintaining meaningful economic exposure to the company. The company remains fundamentally healthy with $7.6B in quarterly revenue, $1.1B in net income, and a P/E of 19.30.

CEO John Q Doyle sold 16,655 MRSH shares at $183.30 on 2026-03-04 ($3.1M); holds 133,466 shares post-sale.

CEO Doyle sold 16,655 shares at $183.30, representing an 11.1% reduction in his holdings. His cross-ticker track record shows 4 prior open-market sales with an average 90-day return of -5.7% and a 75.00% well-timed rate, indicating historically strong timing on sell decisions. The stock is currently trading at $185.00, 2.5% below the 52-week high, and has declined 1.8% over the past 30 days. MRSH fundamentals show strong quarterly revenue of $6,351,000,000.00 with net income of $747,000,000.00 and annual revenue growth of 10.3%. This sale occurs in a stable operational context where the CEO maintains substantial holdings of 133,466 shares post-transaction.

CEO John Q Doyle sells 21,079 shares of MMC at $182.22; stock now -24.9% from 52-week high.

John Q Doyle, President and CEO of Marsh & McLennan Companies, sold 21,079 shares at $182.22 on 2025-12-01, reducing his holdings by 19.4% from 108,760 to 87,681 shares, for a total value of $3,841,015.38. The sale occurs as MMC trades at $183.36 current price, down 24.9% from the 52-week high of $244.27, and carries significance given the insider's seniority and position overseeing the company. His cross-ticker track record shows a 100.00% well-timed rate on prior sells with 3 sales averaging -7.8% over 90 days, and at MMC specifically, all 3 prior sells (2025-09-02, 2025-06-02, 2025-03-03) were well-timed with negative 90-day returns of -10.5%, -11.3%, and -1.4% respectively. The company's fundamentals remain solid—annual revenue growth of +7.6%, net income of $747,000,000.00, and a P/E of 21.78 on a $89.8B market cap—yet the stock has declined 10.7% over 90 days and the CEO is continuing a pattern of well-executed exits at this ticker, suggesting selective conviction about current valuations rather than systemic distress.

CEO Doyle sells 21,079 MMC shares at $205.65 for $4.3M; 90-day track record 100% well-timed

CEO John Q Doyle sold 21,079 shares of Marsh & McLennan at $205.65 on 2025-09-02, reducing his holdings by 19.4% to 87,681 shares. His cross-ticker track record shows a 90-day well-timed rate of 100.00%, with an average 90-day return of -6.4% following his prior sells. At MMC specifically, both of his prior 2 sales have been well-timed at the 90-day mark, including a June 2025 sale followed by a -11.3% decline. The current stock price of $205.27 is -16.0% from its 52-week high of $244.27, suggesting the sale occurred before additional weakness. With revenue of $6,974,000,000 and net income of $1,211,000,000, MMC remains a large, profitable enterprise; the P/E of 24.47 is elevated relative to growth of 7.6%. The timing and magnitude of this sale, coupled with the insider's demonstrated pattern of selling ahead of declines, merit investor attention.

CEO Doyle sold 21,080 MMC shares at $232.05 ($4.9M); 19.4% reduction in holdings to 87,681 shares.

Doyle John Q, President and CEO of Marsh & McLennan, sold 21,080 shares for $4,891,614.00, reducing his holdings by 19.4% from 108,761 to 87,681 shares. The sale occurred at $232.05, below the current price of $234.86 and within recent trading range. Notably, his prior sell at MMC on 2025-03-03 posted a 90-day return of -1.4%, meaning the stock declined after that earlier sale. His cross-ticker track record shows 1 prior sell with a 90d well-timed rate of 100.00%, indicating a pattern of selling ahead of downturns. The company's fundamentals show solid performance with $7.1B in quarterly revenue, $1.4B net income, and 7.6% annual revenue growth, though the P/E of 28.64 reflects current market valuation.

CEO Doyle sells 21,080 shares of MMC for $5.0M at $237.05, retaining 87,681 shares

Doyle John Q, President and CEO of Marsh & McLennan Companies, sold 21,080 shares on March 3, 2025, at $237.05 per share, representing a -19.4% reduction in his pre-transaction holdings of 108,761 shares. The sale occurred near the 52-week high of $239.48, with the stock currently trading at $236.77. With a P/E of 26.84 and market cap of $116.3B, the company trades at a valuation premium to historical averages, though recent quarterly revenue of $5.7B and net income of $747.0M reflect solid near-term operational performance. The CEO retains substantial equity exposure (87.7K shares post-sale), suggesting continued alignment despite the material reduction in holdings.